Your browser doesn't support javascript.
loading
Empagliflozin lessened cardiac injury and reduced visceral adipocyte hypertrophy in prediabetic rats with metabolic syndrome.
Kusaka, Hiroaki; Koibuchi, Nobutaka; Hasegawa, Yu; Ogawa, Hisao; Kim-Mitsuyama, Shokei.
Affiliation
  • Kusaka H; Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjo, Kumamoto, 860-8556, Japan.
  • Koibuchi N; Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjo, Kumamoto, 860-8556, Japan.
  • Hasegawa Y; Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjo, Kumamoto, 860-8556, Japan.
  • Ogawa H; Department of Cardiovascular Medicine, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan.
  • Kim-Mitsuyama S; Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjo, Kumamoto, 860-8556, Japan. mitsuyam@gpo.kumamoto-u.ac.jp.
Cardiovasc Diabetol ; 15(1): 157, 2016 Nov 11.
Article in En | MEDLINE | ID: mdl-27835975

Full text: 1 Database: MEDLINE Main subject: Prediabetic State / Benzhydryl Compounds / Cardiomegaly / Metabolic Syndrome / Intra-Abdominal Fat / Adiposity / Adipocytes, White / Glucosides / Hypoglycemic Agents Type of study: Prognostic_studies Limits: Animals Language: En Year: 2016 Type: Article

Full text: 1 Database: MEDLINE Main subject: Prediabetic State / Benzhydryl Compounds / Cardiomegaly / Metabolic Syndrome / Intra-Abdominal Fat / Adiposity / Adipocytes, White / Glucosides / Hypoglycemic Agents Type of study: Prognostic_studies Limits: Animals Language: En Year: 2016 Type: Article